Skip to content

Research paper

Omega 6 fatty acids for the primary prevention of cardiovascular disease.

The Cochrane database of systematic reviews
Q1
Nov 2015
Citations: 71
Influential: 1
Systematic Reviews / Meta-Analyses
87

Study answer

What this study found

No cardiovascular event data were available. Increasing omega-6 intake did not show consistent effects on blood pressure or lipid levels, and decreasing omega-6 intake likewise showed no clear benefit across the small trials. Examples of reported 24-week results included modest within-group changes in systolic and diastolic blood pressure and mixed, small changes in total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides, without a consistent direction across studies. Overall, evidence was very limited and at risk of bias, so firm conclusions about cardiovascular benefit or…

Study & population
Systematic review of randomized primary-prevention trials in adults without established cardiovascular disease.
Intervention
Across the included randomized trials, omega-6 intake was altered by providing specific foods, spreads, and oils or by giving CLA capsules.
Key limitation
Evidence came from only a small number of short trials with 664 participants in total and 24-week follow-up.
View sourceOpen PDF

Original abstract

BACKGROUND Omega 6 plays a vital role in many physiological functions but there is controversy concerning its effect on cardiovascular disease (CVD) risk. There is conflicting evidence whether increasing or decreasing omega 6 intake results in benefi…